Thanks to John Gerlach, PhD, Professor and Director of the Biomedical Laboratory Diagnostics Program at Michigan State University for the heads-up on this Transfusion Journal article about high hematocrit and thrombosis, which cites two 2017 Blood publications describing several arterial experiments in mice that could have clinical implications.

This June 29, 2016 note was posted by Patricia Boyer, MS, MLS, Program Director, Zablocki VAMC School of Medical Technology to the American Society for Clinical Laboratory Science educators bulletin board: I am working on my hemostasis curriculum, and I was wondering how many instructors teach coagulation using the multicomponent complexes–specifically the tenase and prothrombinase complexes concepts. This is my second year […]

Heartwire reviews a Februay 24 JAMA report indicating that AMI patients on DAPT who use NSAIDs double their risk of bleeding and secondary cardiovascular events. Read about it in Medscape.

Donna Castellone of New York Presbyterian posted an interesting discussion of emotional stress and inflammatory markers in her column, “Don’t Worry, Be Happy,” linked here.  

From Lynn Gingras, MT (ASCP), Rush-Copley Medical Center: Our institution is getting several complaints from the cardiologists as to the turnaround time of the heparin-induced platelet antibody (HIPA, heparin-induced thrombocytopenia with thrombosis, HIT, HITT) testing that we currently send out to a reference lab. Is there any value to bringing in the Akers Bioscience Particle ImmunoFiltration Assay (PIFA) […]

Here is some encouraging information about hormone replacement therapy (HRT) from the Danish Osteoporosis Prevention Study, published October 9, 2012.